Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Citation: Flu antiviral baloxavir shows promise over other treatments for high-risk patients, shortening symptom duration (2025, January 16) retrieved 9 February 2025 from https://medicalxpress ...

Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic review and meta ...